Skip to main content
Clinical Trials/CTRI/2021/05/033625
CTRI/2021/05/033625
Completed
Phase 2

A prospective comparative study between conventional fractionated radiotherapy and hypofractionated radiotherapy by using 3D-CRT technique with respect to toxicity and quality of life in postmastectomy breast carcinoma.

Chittaranjan National Cancer Institute0 sites52 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Chittaranjan National Cancer Institute
Enrollment
52
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 7, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Age greater than equal to 18years and less than 70years.
  • 2\.Female breast cancer patients.
  • 3\.Histopathologically proven Infiltrating Ductal and Infiltrating Lobular carcinoma of the
  • 4\.Patients who will undergo Modified Radical Mastectomy with adequate Axillary
  • Dissection in our institution and will be indicated for post mastectomy chest wall
  • radiotherapy.
  • 5\.Breast carcinoma patients with documented ER,PR and Her2neu status.
  • 6\.No other primary malignancy in any other parts of the body.
  • 7\.No history of previous any chest wall irradiation.
  • 8\.Eastern Cooperative Oncology Group(ECOG) Performance status 0\-2\.

Exclusion Criteria

  • 1\.Age \<18 years and \>70years.
  • 2\.Male breast cancer patients.
  • 3\.Patients with a histopathological finding other than Invasive Lobular and Ductal
  • 4\.Breast carcinoma patients withdistant metastasis.
  • 5\.Patients with inoperable,clinically fixed,and matted lymph nodes.
  • 6\.Patients with inadequate or no axillary dissection.
  • 7\.Patients with any other primary malignant tumour.
  • 8\.Patients with any chronic dermatological or connective tissue disorders that may interfere
  • with radiation induced acute skin toxicity assessment.
  • 9\.History of any previous chest wall irradiation.

Outcomes

Primary Outcomes

Not specified

Similar Trials